A major real-world study published in early 2026 led by researchers at Johns Hopkins Bloomberg School of Public Health and analysing electronic health records from approximately 175,000 people with T1D in the US found that those taking GLP-1 drugs had a roughly 15% lower five-year risk of major cardiovascular events and a 19% lower risk of end-stage kidney disease, without any increase in hospitalisation for DKA or severe hypoglycemia
MusclePharm said it would be bringing back some of the supplements we had seen from it in the past, and while we still have our fingers crossed for the return of its legendary recovery powerhouse Bullet Proof, it has been following through on its word
Methylcobalamin 1500 mcg, Alpha Lipoic Acid 100 mg, Pyridoxine HCI 3 mg, Folic Acid 1.5 mg Methylcobalamin 1500 Mcg, Alpha Lipoic Acid 100mg, Vitamin D3 1000 Iu , Pyridoxine 3mg, Folic Acid1.5mg
The rationale for testing drug combinations in aging intervention studies
We wish, however, that the 250-count bottle (125 servings) came with longer intervals